BUB1 and pancreatic ductal adenocarcinoma: To date, several studies have demonstrated that BUB1 is significantly upregulated in various types of cancer, such as breast cancer, pancreatic ductal adenocarcinoma, prostate and gastric cancer (12–14), and is associated with unfavorable outcomes.